Prot#EX9536-4665: Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects with Obesity-Related Heart Failure with Preserved Ejection Fraction

Project: Research project

Project Details

StatusActive
Effective start/end date12/2/2112/2/24

Funding

  • Novo Nordisk Inc. (Prot#EX9536-4665)